RFK Jr. continues serving as HHS Secretary with sustained alignment to White House priorities on MAHA initiatives, vaccine policy adjustments, and departmental reorganization. Recent leadership changes at HHS, including senior advisor elevations and operational streamlining ahead of the midterms, underscore ongoing institutional support rather than transition signals. Democratic congressional inquiries, legal challenges over advisory committee appointments, and calls for resignation from some health groups have not produced verified statements, procedural steps, or White House pressure indicating an exit before October 31. Trader pricing at 94.5% for "No" reflects the absence of acute political or institutional catalysts that historically precede cabinet departures, with Kennedy publicly focused on departmental work.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedAn announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Sep 3, 2026, 9:28 AM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...RFK Jr. continues serving as HHS Secretary with sustained alignment to White House priorities on MAHA initiatives, vaccine policy adjustments, and departmental reorganization. Recent leadership changes at HHS, including senior advisor elevations and operational streamlining ahead of the midterms, underscore ongoing institutional support rather than transition signals. Democratic congressional inquiries, legal challenges over advisory committee appointments, and calls for resignation from some health groups have not produced verified statements, procedural steps, or White House pressure indicating an exit before October 31. Trader pricing at 94.5% for "No" reflects the absence of acute political or institutional catalysts that historically precede cabinet departures, with Kennedy publicly focused on departmental work.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions